跳到內容

重度乙型地中海貧血

輸血風險和考量

Seropositivity of hepatitis C, hepatitis B and HIV in chronically transfused β-thalassaemia major patients. (開啟新視窗)

Ansari SH, Shamsi TS, Khan MT, Perveen K, Farzana T, Erum S, Ansari I.

出處‎: J Coll Physicians Surg Pak 2012;22(9):610-1.

檢索‎: PubMed 22980623

DOI碼‎: 09.2012/JCPSP.610611

https://www.ncbi.nlm.nih.gov/pubmed/22980623 (開啟新視窗)

Clinical outcome of frequent exposure to Torque Teno virus (TTV) through blood transfusion in thalassemia patients with or without hepatitis C virus (HCV) infection. (開啟新視窗)

Hu YW, Al-Moslih MI, Al Ali MT, Uzicanin S, Perkins H, Yi QL, Rahimi Khameneh S, Wu J, Brown EG.

出處‎: J Med Virol 2008;80(2):365-71.

檢索‎: PubMed 18098140

DOI碼‎: 10.1002/jmv.21070

https://www.ncbi.nlm.nih.gov/pubmed/18098140 (開啟新視窗)

Prevalence of alloimmunisation in patients with beta thalassaemia major. (開啟新視窗)

Kosaryan M, Mahdavi MR, Roshan P, Hojjati MT.

出處‎: Blood Transfus 2012;10(3):396-7.

檢索‎: PubMed 22395351

DOI碼‎: 10.2450/2012.0072-11

https://www.ncbi.nlm.nih.gov/pubmed/22395351 (開啟新視窗)

Marseillevirus prevalence in multitransfused patients suggests blood transmission. (開啟新視窗)

Popgeorgiev N, Colson P, Thuret I, Chiarioni J, Gallian P, Raoult D, Desnues C.

出處‎: J Clin Virol 2013;58(4):722-5.

檢索‎: PubMed 24183312

DOI碼‎: 10.1016/j.jcv.2013.10.001

https://www.ncbi.nlm.nih.gov/pubmed/24183312 (開啟新視窗)